| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $111,149,134 ) (Continued on the next page) |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R35CA197442 | Targeting 15-Prostaglandin Dehydrogenase (15-PGDH) in Cancer Risk, Prevention, and Treatment | 000 | 6 | NIH | 11/10/2021 | $855,900 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | F30MH122173 | Regulation of Pet1/FEV binding and chromatin accessibility during serotonergic neuron development | 001 | 3 | NIH | 4/26/2022 | $717 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | F30MH122173 | Regulation of Pet1/FEV binding and chromatin accessibility during serotonergic neuron development | 000 | 3 | NIH | 12/17/2021 | $51,036 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R01DE026923 | Amphiregulin-Immunometabolism axis in oral immunity and inflammation during HIV infection | 002 | 6 | NIH | 5/13/2022 | $650,980 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | F30CA257076 | Exploiting convergent evolution to design biomarker extraction tools for the prediction of therapeutic response in cancer | 001 | 2 | NIH | 6/17/2022 | $716 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | F30CA257076 | Exploiting convergent evolution to design biomarker extraction tools for the prediction of therapeutic response in cancer | 000 | 2 | NIH | 12/22/2021 | $51,036 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R35HL135789 | KLF control of aging and age-associated cardiovascular disease | 001 | 6 | NIH | 6/8/2022 | $95,101 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R35HL135789 | KLF control of aging and age-associated cardiovascular disease | 000 | 6 | NIH | 2/2/2022 | $855,899 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R01CA226921 | Role of WAVE3 in the Development and Progression of Breast Cancer | 000 | 5 | NIH | 4/29/2022 | $407,005 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R01GM115234 | Regulatory Mechanisms of Glycoprotein Sialylation | 000 | 6 | NIH | 11/18/2021 | $444,585 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R01NS095895 | Linking an activity-dependent BMP pathway to synapse structure and function | 002 | 7 | NIH | 4/8/2022 | $402,500 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | UG1HD021364 | Eunice Kennedy Shriver NICHD Cooperative Multicenter Neonatal Research Network | 000 | 37 | NIH | 3/31/2022 | $269,386 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | UG1HD021364 | Eunice Kennedy Shriver NICHD Cooperative Multicenter Neonatal Research Network | 001 | 37 | NIH | 5/12/2022 | $29,935 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | UG1HD040544 | Case Western Reserve University Center of the NICHD MFMU | 002 | 23 | NIH | 4/18/2022 | $314,064 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R35GM118088 | Dynamics of RNA-protein interactions | 000 | 7 | NIH | 3/14/2022 | $575,678 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | F31MD015681 | Evaluating and Quantifying the Magnitude and Multilevel Causes of Health Disparities in Understudied Minority People with Epilepsy (EQU-ity) | 000 | 2 | NIH | 5/28/2022 | $35,672 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R01DK112905 | Using Latent Variables And Directly Observed Treatment To Improve The Diagnosis And Management of Depression Among Hemodialysis Patients | 001 | 5 | NIH | 3/25/2022 | $23,337 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R01DK112905 | Using Latent Variables And Directly Observed Treatment To Improve The Diagnosis And Management of Depression Among Hemodialysis Patients | 000 | 5 | NIH | 11/10/2021 | $210,032 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R01HL128053 | The role of the proximal nephron in salt-sensitive hypertension | 000 | 6 | NIH | 11/19/2021 | $573,778 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R01HL128053 | The role of the proximal nephron in salt-sensitive hypertension | 001 | 6 | NIH | 6/8/2022 | $63,755 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | T32NS077888 | Training in Neurodegenerative Diseases | 000 | 9 | NIH | 4/27/2022 | $156,760 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | UM1AI069501 | Case Clinical Trials Unit | 000 | 16 | NIH | 11/30/2021 | $521,614 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | UM1AI069501 | Case Clinical Trials Unit | 001 | 16 | NIH | 6/9/2022 | $673,744 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | UM1AI069501 | Case Clinical Trials Unit | 001 | 16 | NIH | 6/9/2022 | $333,491 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R01CA160356 | The role of gene enhancer elements in colon cancer | 000 | 10 | NIH | 12/16/2021 | $264,131 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R01CA160356 | The role of gene enhancer elements in colon cancer | 001 | 10 | NIH | 5/5/2022 | $23,479 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | UM1AI069501 | Case Clinical Trials Unit | 000 | 16 | NIH | 11/30/2021 | $1,053,805 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R01NS082007 | Mechanisms of neuromuscular junction formation | 000 | 11 | NIH | 5/13/2022 | $564,117 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R01HL121212 | Heteromutivalent Peptide-Lipid Nanoconstructs as Artificial Platelet Analogues | 000 | 7 | NIH | 2/25/2022 | $479,470 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R01HL121212 | Heteromutivalent Peptide-Lipid Nanoconstructs as Artificial Platelet Analogues | 001 | 7 | NIH | 6/15/2022 | $53,276 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R01EY023948 | Regulation of vitamin A metabolism in the eye | 000 | 8 | NIH | 1/21/2022 | $446,646 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | P30DK097948 | The Cleveland Digestive Diseases Research Core Center (DDRCC) | 000 | 8 | NIH | 1/25/2022 | $1,054,148 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | P30DK097948 | The Cleveland Digestive Diseases Research Core Center (DDRCC) | 001 | 8 | NIH | 3/30/2022 | $117,127 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | D43TW010319 | Microbiology and Immunology Training for HIV and HIV-Related Research in Uganda (MITHU) | 002 | 7 | NIH | 3/15/2022 | $50,000 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | D43TW010319 | Microbiology and Immunology Training for HIV and HIV-Related Research in Uganda (MITHU) | 002 | 7 | NIH | 3/15/2022 | $248,161 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R01HL126747 | Optical Tools to Assess the Role of Cardiac Function in the Development of Congenital Heart Defects | 000 | 7 | NIH | 3/16/2022 | $697,408 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R01HL126747 | Optical Tools to Assess the Role of Cardiac Function in the Development of Congenital Heart Defects | 001 | 7 | NIH | 6/18/2022 | $77,492 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R01AI063517 | Challenges in beta-Lactamase Mediated Resistance | 000 | 14 | NIH | 12/20/2021 | $391,023 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R01CA216579 | Computerized Histologic Risk Predictor (CHiRP) for Early Stage Lung Cancers | 001 | 5 | NIH | 5/5/2022 | $48,834 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R01CA216579 | Computerized Histologic Risk Predictor (CHiRP) for Early Stage Lung Cancers | 000 | 5 | NIH | 12/16/2021 | $549,370 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | K23AI132644 | Epigenetic Reprogramming of Monocyte Functions during Acute Uncomplicated Malaria in Kenyan Children | 000 | 5 | NIH | 12/6/2021 | $189,575 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R01CA222064 | Hes1-loss promotes dysregulation of epithelial homeostasis and inflammation in a serrated adenocarcinoma model | 000 | 5 | NIH | 6/20/2022 | $406,859 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R01NS114120 | Low-frequency stimulation of fiber tracts to control seizures | 000 | 3 | NIH | 11/1/2021 | $301,062 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R01NS114120 | Low-frequency stimulation of fiber tracts to control seizures | 001 | 3 | NIH | 3/23/2022 | $33,450 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R01CA236273 | Role of the lncRNA BORG in Breast Cancer Metastatic Progression and Recurrence | 001 | 4 | NIH | 4/29/2022 | $36,515 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R01CA236273 | Role of the lncRNA BORG in Breast Cancer Metastatic Progression and Recurrence | 000 | 4 | NIH | 11/11/2021 | $410,791 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R01CA235152 | Smart nanoparticles regulating oncogenic IncRNA for breast cancer therapy | 002 | 4 | NIH | 5/16/2022 | $28,589 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R01CA235152 | Smart nanoparticles regulating oncogenic IncRNA for breast cancer therapy | 003 | 4 | NIH | 5/17/2022 | $6,094 |
| | 2022 | 2022 | CASE WESTERN RESERVE UNIVERSITY | 10900 EUCLID AVE | CLEVELAND | OH | 44106-1712 | CUYAHOGA | USA | R01CA235152 | Smart nanoparticles regulating oncogenic IncRNA for breast cancer therapy | 000 | 4 | NIH | 11/30/2021 | $321,624 |
|
